Magnesium → HCID 178484159, 화합물

HRID 1679644노트

반응식

HRID 1679644 반응식
[Mg:1].[CH3:2][C@:3]1([OH:33])[C@@H:17]2[C:12](=[C:13]([OH:31])[C@:14]3([OH:30])[C:21](=[O:22])[C:20]([C:23]([NH2:25])=[O:24])=[C:19]([OH:26])[C@@H:18]([N:27]([CH3:29])[CH3:28])[C@@H:15]3[CH2:16]2)[C:10](=[O:11])[C:9]2[C:8]([OH:32])=[CH:7][CH:6]=[CH:5][C:4]1=2>>[Mg:1].[CH3:2][C@:3]1([OH:33])[C@@H:17]2[C:12](=[C:13]([OH:31])[C@:14]3([OH:30])[C:21](=[O:22])[C:20]([C:23]([NH2:25])=[O:24])=[C:19]([OH:26])[C@@H:18]([N:27]([CH3:29])[CH3:28])[C@@H:15]3[CH2:16]2)[C:10](=[O:11])[C:9]2[C:8]([OH:32])=[CH:7][CH:6]=[CH:5][C:4]1=2

참가 물질

3

실험 절차

Magnesium ions combine with tetracycline in solution to form magnesium-tetracycline chelates. Magnesium oxide is a convenient and preferred source of magnesium ions, but other magnesium compounds useful for the purpose of this invention include magnesium chloride, magnesium acetate and magnesium sulfate. The molar ratio of magnesium to tetracycline in these compositions is about from 0.8 to 1.3 mole. This ratio is advisable to produce clear stable solutions.

출처 및 근거

ORD 기록
ord-f59850fea1244b58a0342569b59690df
출처 데이터셋
uspto-grants-1978_03
특허 번호
US04081528

반응 노트

불러오는 중…